Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 806,474 |
|
|||||
| News | - | ||||||
| Day High | 406.825 | Low High |
|||||
| Day Low | 399.29 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vertex Pharmaceuticals Inc | VRTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.91 | -0.22% | 404.00 | 19:55:27 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 404.50 | 399.29 | 406.825 | 400.76 | 404.91 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 25,833 | 806,474 | $ 402.29 | $ 324,437,796 | - | 316.43 - 448.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:57:18 | 65 | $ 403.00 | USD |
Vertex Pharmaceuticals (VRTX) Options Flow Summary
Vertex Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 103.52B | 258.31M | - | 9.92B | 3.57B | 13.82 | 28.99 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Vertex Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VRTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 394.94 | 406.86 | 391.01 | 397.37 | 1,127,177 | 9.06 | 2.29% |
| 1 Month | 420.30 | 421.45 | 391.01 | 402.83 | 978,211 | -16.30 | -3.88% |
| 3 Months | 441.57 | 444.07 | 391.01 | 415.70 | 1,183,124 | -37.57 | -8.51% |
| 6 Months | 365.63 | 448.40 | 341.90 | 401.09 | 1,330,409 | 38.37 | 10.49% |
| 1 Year | 331.06 | 448.40 | 316.43 | 375.99 | 1,235,746 | 72.94 | 22.03% |
| 3 Years | 217.74 | 448.40 | 176.36 | 281.10 | 1,510,264 | 186.26 | 85.54% |
| 5 Years | 175.58 | 448.40 | 164.07 | 258.26 | 1,543,314 | 228.42 | 130.09% |
Vertex Pharmaceuticals Description
| Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes. |
